EMEA-002342-PIP02-18-M01
Key facts
Invented name |
Verzenios
|
Active substance |
abemaciclib
|
Therapeutic area |
Oncology
|
Decision number |
P/0439/2021
|
PIP number |
EMEA-002342-PIP02-18-M01
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Eli Lilly and Company Limited (US)
Tel.: +1 31 75448941 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|